Antepartum management and obstetric outcomes among pregnancies with Down syndrome from diagnosis to delivery
- PMID: 28419500
- DOI: 10.1002/pd.5054
Antepartum management and obstetric outcomes among pregnancies with Down syndrome from diagnosis to delivery
Abstract
Objective: Little is known about the obstetric care of an ongoing pregnancy with trisomy 21. We sought to ascertain an obstetric profile for pregnancies with Down syndrome to help guide prenatal management.
Method: Pregnancies managed for delivery with trisomy 21 between 2003 and 2014 were analyzed. We reviewed demographic data, diagnostic testing, prenatal surveillance, obstetric outcomes, and placental pathology. T-test, chi-squared test, and Fisher correction were used as indicated.
Results: Sixty-eight pregnancies were identified, and four women (5.9%) experienced a loss during the pregnancy. Among the remaining 64 pregnancies, the average gestational age at delivery was 36.9 weeks, growth restriction was present in 12 (17.5%), and major anomalies were present in 51 (75.0%). Delivery was undertaken for non-reassuring fetal surveillance in 35.9% of the pregnancies; 93% of which represented a change from prior reassuring surveillance and 52.6% of which demonstrated histopathologic evidence of placental insufficiency. None among increased maternal age, the presence of an anomaly, or growth restriction were significantly more common in the group with non-reassuring surveillance.
Conclusion: There are high rates of fetal growth restriction, delivery for non-reassuring fetal status, and evidence of placental insufficiency among affected pregnancies, suggesting a role for antepartum surveillance. © 2017 John Wiley & Sons, Ltd.
© 2017 John Wiley & Sons, Ltd.
Similar articles
-
Prenatal screening for fetal aneuploidy in singleton pregnancies.J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1. J Obstet Gynaecol Can. 2011. PMID: 21749752
-
Obstetrical complications associated with abnormal maternal serum markers analytes.J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5. J Obstet Gynaecol Can. 2008. PMID: 19038077 Review. English, French.
-
Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.Ultrasound Obstet Gynecol. 2017 Jun;49(6):721-728. doi: 10.1002/uog.17228. Ultrasound Obstet Gynecol. 2017. PMID: 27515011 Free PMC article.
-
Down-regulation of placental neuropilin-1 in fetal growth restriction.Am J Obstet Gynecol. 2016 Feb;214(2):279.e1-279.e9. doi: 10.1016/j.ajog.2015.09.068. Epub 2015 Sep 26. Am J Obstet Gynecol. 2016. PMID: 26409917
-
Multifetal pregnancies.Curr Opin Obstet Gynecol. 1995 Dec;7(6):465-71. Curr Opin Obstet Gynecol. 1995. PMID: 8620081 Review.
Cited by
-
Embryonic statistical analyses reveal 2 growth phenotypes in mouse models of Down syndrome.Am J Obstet Gynecol. 2024 Feb;230(2):258.e1-258.e11. doi: 10.1016/j.ajog.2023.07.056. Epub 2023 Aug 6. Am J Obstet Gynecol. 2024. PMID: 37544351 Free PMC article.
-
Placental development and function in trisomy 21 and mouse models of Down syndrome: Clues for studying mechanisms underlying atypical development.Placenta. 2020 Jan 1;89:58-66. doi: 10.1016/j.placenta.2019.10.002. Epub 2019 Oct 5. Placenta. 2020. PMID: 31683073 Free PMC article. Review.
-
Unique Challenges of NIPT for Sex Chromosome Aneuploidy.Clin Obstet Gynecol. 2023 Sep 1;66(3):568-578. doi: 10.1097/GRF.0000000000000804. Epub 2023 Jul 24. Clin Obstet Gynecol. 2023. PMID: 37650669 Free PMC article.
-
Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?Prenat Diagn. 2017 Dec;37(13):1281-1290. doi: 10.1002/pd.5182. Prenat Diagn. 2017. PMID: 29111614 Free PMC article. Review.
-
Outcome after Prenatal Diagnosis of Trisomy 13, 18, and 21 in Fetuses with Congenital Heart Disease.Life (Basel). 2022 Aug 12;12(8):1223. doi: 10.3390/life12081223. Life (Basel). 2022. PMID: 36013402 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical